1. ICDs, Pacemakers Okay for Oldest Patients. Age should not be a barrier to treatment with permanent pacemakers or implantable cardioverter-defibrillators (ICDs).
2. Young Ca Survivors Face Lifelong Risk of More Cancers. One in 10 childhood cancer survivors faces a lifelong risk of developing at least one subsequent neoplasm, particularly if they were treated with radiation.
3. Seizure Drug Trial Called a Form of Marketing. A postmarketing study of the epilepsy drug gabapentin (Neurontin) sponsored by its manufacturer was intended mainly to turn its hundreds of clinician-investigators into enthusiasts for the product.
Similar Posts:
- Experimental Drug Might Help Some a Bit With Colon Cancer (HealthDay)
- Top stories in health and medicine this morning, July 2, 2011
- Atrial fibrillation trial halted; Multaq linked to other heart problems
- Cellean Review
- First Drug Ok’d to Combat Spreading Basal Cell Skin Cancer
